New drug tested to wipe out prostate cancer before surgery
NCT ID NCT07208292
Summary
This study aims to see if giving the drug rezvilutamide to men before their prostate cancer surgery helps eliminate more cancer cells and prevents the cancer from coming back. It will enroll 115 men with high-risk or locally advanced prostate cancer who are scheduled for surgery. Researchers will track whether the drug leads to no detectable cancer in the removed tissue and monitor for signs of recurrence after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREOPERATIVE EVALUATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.